Thilo Jakob to Chronic Disease
This is a "connection" page, showing publications Thilo Jakob has written about Chronic Disease.
Connection Strength
0.041
-
Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence. J Allergy Clin Immunol. 2018 02; 141(2):638-649.
Score: 0.015
-
H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study. Clin Exp Allergy. 2017 May; 47(5):684-692.
Score: 0.015
-
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013 Jul; 132(1):101-9.
Score: 0.011